Table 1.

Factors associated with disclosure of HIV status among men and transgender women classified as previously diagnosed who were screened for participation in HPTN 075.^*

Variables	Previously-diagnosed study participants (N=103)
	Total	HIV status disclosed (N, %)	OR (95% CI)	p-value
Age
18–25 years	48	34 (70.8%)	ref
26–44 years	55	33 (60.0%)	0.62 (0.27–1.41)	0.25
Study site
Kisumu, Kenya	23	10 (43.5%)	ref
Blantyre, Malawi	13	9 (69.2%)	2.92 (0.69–12.32)	0.14
Cape Town, South Africa	18	10 (55.6%)	1.62 (0.47–5.63)	0.44
Soweto, South Africa	49	38 (77.6%)	4.49 (1.55–13.00)	0.006
Gender identificationa
Male	66	41 (62.1%)	ref
Transgender	37	26 (70.3%)	1.44 (0.61–3.42)	0.41
Ever had sex with women
No	53	42 (79.2%)	ref
Yes	50	25 (50.0%)	0.26 (0.11–0.62)	0.002

^*The table shows factors associated with disclosure of HIV status among 103 participants who were confirmed to be HIV infected in the study and who were classified as previously diagnosed. Two groups were compared; those who reported a prior HIV diagnosis at screening, and those who did not report a prior HIV diagnosis, but had ARV drugs detected in the sample from their screening visit. Sixty-seven participants reported that their last HIV test was positive (HIV status disclosed, Yes). Thirty-six participants did not report a previous positive HIV test, but were classified as previously diagnosed based on results of antiretroviral (ARV) drug testing (HIV status disclosed: No, see text). Data for variables shown in the table were collected at the screening visit. p<0.05 is bolded. Abbreviations: N: number; OR: odds ratio; CI: confidence interval, ref: reference.

^aParticipants who identified as female, male and female, and/or transgender were classified as transgender.